Pharmafile Logo
Pharmafocus logo
Advanced Search

neuroscience

Showing 15 posts of 27 posts found.

Draig Therapeutics appoints Ivana Magovčević-Liebisch as President and CEO

November 5, 2025
Draig Therapeutics, Neuropsychiatry, neuroscience

Draig Therapeutics, a Welsh clinical-stage company developing glutamate and GABA-based treatments for neuropsychiatry, has appointed Ivana Magovčević-Liebisch as President and …

Appointment
Brain image

Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse

July 18, 2025
Medical Communications, Research and Development CAPLYTA, Johnson & Johnson, Neurology, US Food and Drug Administration, neuroscience, new drug application, schizophrenia

Johnson & Johnson has submitted a supplemental New Drug Application to the US Food and Drug Administration (FDA) for Caplyta …

News

Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth

July 16, 2025
Research and Development CEO, Corporate, Neurology, Oncology, jazz pharmaceuticals, neurology, neuroscience

Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president …

Appointment
brainss

Abbvie acquires Cerevel Therapeutics

August 2, 2024
Mergers and Acquisitions AbbVie, Cerevel Therapeutics, Drug-Resistant Epilepsy, Neurology, Parkinson's disease, major depressive disorder, mergers & acquisitions, neurology, neuroscience, schizophrenia

Abbvie has announced the acquisition of Cerevel Therapeutics, strengthening its neuroscience pipeline. Cerevel has multiple programmes across neurological and psychiatric …

News

Evotec shares progress in Bristol Myers Squibb neuroscience collaboration

June 12, 2024
Research and Development Evotec, Neurology, bristol myers squibb, neuroscience

Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

May 5, 2023
Medical Communications Cognixion, FDA, Neurology, brain computer interface, breakthrough device designation, neuroscience

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and …

News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021
Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …

News
schizophrenia

Acadia’s schizophrenia drug flops in Phase 3 trial

July 23, 2019
Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia

Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …

News

Takeda opens R&D facility in San Diego, California

May 2, 2019
Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News

CBD could be used to deliver drugs into the brain, research shows

April 18, 2019
Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience

Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …

News
neurons-3743011_960_720

Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding

February 26, 2019
Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d

Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …

News
psm_v46_d168_mesial_view_of_the_human_brain

Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows

August 30, 2018
Research and Development MS, brain, ibudilast, neuroscience, research

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …

News
vagus_nerve_stimulation

Nerve stimulation treatments improve quality of life in depressed people, study shows

August 23, 2018
Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators

Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …

News
30614937102_31ec4db2fa_z

Prozac prevents cognitive decline during normal aging process, study shows

August 21, 2018
Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience

A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026